Reported Reactions

Devices › Implant, endosseous, root-form

Device brand name · Endosseous dental implant

NobelActive TiUltra 3.0 3.0x15mm: medical device reports filed with FDA

300 reports name it, 2021–2026. Manufacturer given most often on reports: Nobel Biocare. Product code DZE.

300
device reports naming the brand
0% of all MAUDE reports · about 56 a year
52
reports, 12 months to August 2026
66 in the 12 months before
3.3%
classified as malfunction
0.8% across the product code
0%
classified as death, as reported
0 reports · not verified by FDA

FDA's MAUDE database holds 300 reports that name the brand "NobelActive TiUltra 3.0 3.0x15mm" (endosseous dental implant), received between March 2021 and August 2026; the manufacturer given most often on reports is Nobel Biocare. Spellings of one product vary from report to report.

52 reports arrived in the 12 months to August 2026, down 21% from 66 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (96.7%) and malfunction (3.3%); across all implant, endosseous, root-form reports (product code DZE) death is recorded in 0% and malfunction in 0.8%. Event type is the reporter's classification of the report, not a verified outcome.

The device problems coded most often are failure to osseointegrate (75.3%), osseointegration problem (8%) and loss of osseointegration (5.3%). The patient problems coded most often are failure of implant, pain and appropriate clinical signs, symptoms and conditions term/code not available. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Reports by month, five years

0816Sep 2021: 4Oct 2021: 4Nov 2021: 8Dec 2021: 42022Jan 2022: 2Feb 2022: 0Mar 2022: 0Apr 2022: 0May 2022: 6Jun 2022: 4Jul 2022: 2Aug 2022: 2Sep 2022: 8Oct 2022: 12Nov 2022: 4Dec 2022: 62023Jan 2023: 8Feb 2023: 2Mar 2023: 0Apr 2023: 4May 2023: 8Jun 2023: 2Jul 2023: 0Aug 2023: 0Sep 2023: 6Oct 2023: 4Nov 2023: 4Dec 2023: 62024Jan 2024: 4Feb 2024: 10Mar 2024: 10Apr 2024: 6May 2024: 8Jun 2024: 8Jul 2024: 4Aug 2024: 4Sep 2024: 14Oct 2024: 8Nov 2024: 4Dec 2024: 82025Jan 2025: 8Feb 2025: 6Mar 2025: 0Apr 2025: 0May 2025: 0Jun 2025: 0Jul 2025: 16Aug 2025: 2Sep 2025: 6Oct 2025: 2Nov 2025: 4Dec 2025: 142026Jan 2026: 4Feb 2026: 6Mar 2026: 4Apr 2026: 0May 2026: 2Jun 2026: 4Jul 2026: 0Aug 2026: 6

Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.

By year received

044882021: 3820212022: 4620222023: 4420232024: 8820242025: 5820252026: 262026

Event type and report source

Event type, as classified on the report

Death0%0
Injury96.7%290
Malfunction3.3%10
Other0%0
Not given0%0

Who filed the report

Manufacturer report50%150
Voluntary report0%0
User facility report0%0
Distributor report50%150
Not given0%0

Grey bar: all 3,924,241 reports carrying product code DZE. Event type is the filer's classification and is not verified by FDA.

Device problems coded

Device problem (FDA code)ReportsShareShare across product code
Failure to osseointegrate22675.3%62.8%
Osseointegration problem248%7.7%
Loss of osseointegration165.3%22.4%
Insufficient device problem information41.3%0.2%
Migrationthe device moved from where it was placed41.3%0.1%
Premature separation41.3%0.1%
Activation, positioning or separation problem20.7%0%
Difficult to insertthe device was hard to insert20.7%0.4%
Fracturea broken bone20.7%1.6%
Patient device interaction problem20.7%0.3%

FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.

Patient problems coded

Patient problem (FDA code)ReportsShare
Failure of implant22274%
Painpain, site not specified186%
Appropriate clinical signs, symptoms and conditions term/code not available62%
Foreign body in patientpart of a device left in the patient41.3%
Implant pain41.3%
Abscessa collection of pus20.7%
Fistula20.7%
Inflammationinflammation20.7%

Patient problem codes are present mainly in reports filed since 2019 and are often blank.

In context

MeasureNobelActive TiUltra 3.0 3.0x15mmProduct code DZEAll MAUDE reports
Reports3003,924,24126,136,888
Share of that pool—0%0%
Classified as death, per 1,000 reports009
Classified as injury96.7%99.2%36.2%
Classified as malfunction3.3%0.8%62.3%
Filed by the manufacturer50%77.7%94.9%

Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."

Other brands with product code DZE

BrandReportsLatest 12 monthsClassified as death
Biohorizons Dental Implant58,73200%
BioHorizons Inc.57,02025,5360%
NobelActive Internal RP 4.3x10mm49,0989,5280%
BLT ?4.1mm RC, SLA? 10mm, TiZr, Loxim45,6509,6770%
NobelParallel CC RP 4.3x10mm44,2699,3180%
BLT ?4.1mm RC, SLActive? 10mm, TiZr, NTP41,6727,5310%
Unknown Implant39,9671,4540%
NobelReplace CC RP 4.3x10mm35,9468,1660%
NobelReplace CC PMC RP 4.3x10mm34,4478,6900%
NobelActive Internal RP 4.3x11.5mm33,1175,7040%
BLT ?3.3mm NC, SLA? 10mm, TiZr, Loxim28,6485,6950%
BLT ?4.1mm RC, SLA? 10mm, Ti, Loxim26,7248,4810%
BLT ?3.3mm NC, SLActive? 10mm, TiZr, NTP26,5404,6800%
NobelActive Internal RP 4.3x13mm25,5563,7640%
BLT ?4.1mm RC, SLA? 8mm, TiZr, Loxim24,7725,9780%

Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."

Questions about NobelActive TiUltra 3.0 3.0x15mm reports

How many FDA reports name NobelActive TiUltra 3.0 3.0x15mm?

300 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 52 in the latest 12 months.

What kinds of events are reported?

injury (96.7%) and malfunction (3.3%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.

What device problems are coded?

failure to osseointegrate (75.3%), osseointegration problem (8%), loss of osseointegration (5.3%), insufficient device problem information (1.3%) and migration (1.3%). These are FDA's device problem codes as entered on the report.

Who files these reports?

manufacturer reports (50%) and distributor reports (50%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.

Do these reports show that NobelActive TiUltra 3.0 3.0x15mm was at fault?

No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."

How do I report a problem with a medical device?

Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.

Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.

Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.